Berte, Benjamin
Valeriano, Chiara
Rissotto, Sophie
Sigal, Alona
Klemm, Ofer
Mahida, Saagar
De Potter, Tom
Pürerfellner, Helmut
Kobza, Richard
Article History
Received: 26 August 2024
Accepted: 17 March 2025
First Online: 27 March 2025
Declarations
:
: B.B. received proctoring, lecture, traveling, and consulting fees from Biosense Webster. R.K. and S.M. received research grants and consulting fees from Biosense Webster. H.P. has received honoraria/consultation fees from Abbott, Biosense Webster, Boston Scientific, and Medtronic. S.R., A.S, and O.K. are employees of Biosense Webster: S.R. acted as the connection between the clinical field and R&D department, consistently annotated cases on the 3D mapping system, and ensured information was transmitted to the R&D department based on the experience in the case. A.S. was the lead developer of the algorithm and provided invaluable assistance in analyzing the ablations and the algorithm behavior. K.O. was the vice lead in developing the algorithm within the R&D department. He contributed to understanding the behavior of the algorithm in specific applications and helped us understand its clinical significance. None of the other authors declared a conflict of interest.